OXFORD BIOMEDICA

DOUBLE FIRST FOR OXFORD BIOMEDICA

Research Director Receives Professorship from Oxford University

Oxford BioMedica plc, a world leader in retroviral gene delivery technologies, announced today that Research Director and co-founder, Sue Kingsman, has been made Professor of Molecular Genetics by Oxford University. This is in recognition of her international contribution to the fields of gene expression and retrovirus biology.

Commenting on the award Professor Sue Kingsman said: 'I am delighted by this honour and by the support that the University has given to my work, both within the University and Oxford BioMedica'.

With Sue Kingsman's appointment, Oxford BioMedica can now claim two Professors amongst it's executive board members. Alan Kingsman, Chief Executive and Professor of Biochemistry, and Sue Kingsman established the Company in 1995. Since then the husband and wife team have worked together to commercialise the technologies developed in over 17 years of research in the University laboratories.

Professor Kingsman's appointment further strengthens Oxford BioMedica's relationship with the University. The support and confidence in Oxford BioMedica's technology and the commercial acumen of the management is signified by both this appointment and the 17% shareholding that the University has in the Company.

Oxford BioMedica's Finance Director, Andrew Wood said: 'We have an excellent working relationship with the University, including several collaborative programmes designed to bring new commercial technologies to the Company. This will be further enhanced by Sue Kingsman holding this very senior post'.

Notes to Editors

1. Oxford BioMedica, established in 1995, specialises in the development and application of gene-based therapeutics using advanced retroviral gene delivery technologies for the treatment of disease in the areas of: oncology, viral infection, neurobiology and genetic deficiency. Oxford BioMedica plc was floated on the UK Alternative Investment Market of the London Stock Exchange in December 1996.